Hydrophilic Matrix Sustained Release Tablets of Lappaconite Hydrobromide:Preparation and Release in Vitro

GAO Yuan,LI Fengying,LIU Ling,LI Weiwen,HE Jing,ZHONG Haijun

DOI: https://doi.org/10.13748/j.cnki.issn1007-7693.2013.07.001

2013-01-01

Abstract:OBJECTIVE To reduce the frequency of administration,enhance patient compliance,increase antinociceptive effect of lappoconitine hydrobromide,hydrophilic matrix sustained release tablets of lappaconite hydrobromide were prepared.The formulations of the tablets were optimized.Then the in vitro release models were also evaluated in present study.METHODS The effects of various molecular masses and contents of HPMC(using as hydrophilic matrix),various contents of lactose(filling agent),microcrystalline cellulose(filling agent),starch(filling agent) and magnesium stearate(lubricant) on drug release from the matrix tablets in vitro were investigated,respectively.The in vitro release mechanism of the optimal formulation was discussed by fitting various models.RESULTS The results showed that the molecular mass and the content of HPMC,the contents of microcrystalline cellulose and magnesium stearate influenced greatly on drug release in vitro from the tablets.No burst drug release from the obtained matrix tablets was observed.Drug release in vitro sustained up to 12 h.It was better agreed with first-order kinetics model,which indicated that drug release from the tablets was controlled by drug diffusion from the hydrophilic gel and degradation of the matrix.CONCLUSION The obtained hydrophilic matrix tablets of lappaconite hydrobromide in present study had many advantages,such as ease of manufacturing,low production costs and good performance of drug release,etc.